Comparing Class Actions and Multidistrict Litigation: How the Federal Courts Manage Mass Claims

On December 1, 2025, Federal Rule of Civil Procedure 16.1 took effect, marking the first time the federal judiciary implemented a rule specifically designed to manage multidistrict litigation (MDL). The new rule arrived as the federal courts grappled with a massive and unprecedented concentration of cases. By the end of 2024, the U.S. district courts held 536,766 pending civil cases, a figure that reflects a judiciary under immense pressure from aggregated claims. A significant percentage of these complex product liability and mass tort lawsuits are now housed not in traditional class actions, but in MDLs, fundamentally altering how the federal system processes civil disputes. The implementation of Rule 16.1 represents an acknowledgment that the procedural mechanisms of the past century are struggling to contain the sheer volume of modern mass litigation.[1][5][6]

The public imagination frequently equates mass civil lawsuits with the class action, envisioning a single representative plaintiff standing in for thousands of wronged consumers. Yet the divergence between the class action and the MDL stems from the distinct procedural thresholds required to aggregate those claims. A class action is governed by Rule 23 of the Federal Rules of Civil Procedure, which allows one or more plaintiffs to sue on behalf of a larger group, provided they meet strict criteria. An MDL, governed by 28 U.S.C. § 1407, is a procedural tool that transfers individual cases pending in different federal districts to a single judge for coordinated pretrial proceedings. While both mechanisms seek to efficiently resolve widespread harm, they operate under entirely different legal frameworks and produce vastly different settlement structures.[1][2][3][4]

To successfully certify a class action, plaintiffs must satisfy four rigorous prerequisites outlined in Rule 23(a): numerosity, commonality, typicality, and adequacy of representation. The presiding judge must rigorously analyze whether the representative plaintiff's claims are truly typical of the absent class members, and whether common legal or factual questions predominate over individual issues. This "predominance" requirement is often the death knell for mass torts. If a defective drug causes varying side effects in different patients, or if plaintiffs have distinct medical histories, the court will likely deny class certification on the grounds that individual questions overwhelm the common ones. If the class is certified, however, the representative plaintiff litigates the case for everyone, and the absent members are bound by the outcome unless they explicitly opt out.[2][4][6]

In stark contrast, the Judicial Panel on Multidistrict Litigation (JPML) can centralize cases into an MDL if they merely share "one or more common questions of fact." There is no requirement that the claims be typical, nor is there a mandate that a representative plaintiff adequately represent the whole. Each plaintiff in an MDL retains their individual lawsuit and their own legal counsel; they are simply grouped together in a single transferee court for the purpose of streamlining discovery and resolving pretrial motions. This lower barrier to entry allows the federal judiciary to consolidate thousands of highly individualized claims—such as those involving complex medical devices or toxic exposure—that could never survive the rigorous certification process of a Rule 23 class action.[1][3][6]

Because mass torts frequently fail the predominance test required for class certification, plaintiffs' attorneys have increasingly utilized the MDL process to aggregate claims. The lower threshold of 28 U.S.C. § 1407 allows law firms to build massive inventories of individual cases and leverage them for global settlements. This shift has resulted in extreme concentration within the federal docket. Rather than dispersing cases across the country, the JPML funnels tens of thousands of claims to a handful of transferee judges, who are then tasked with managing sprawling dockets that can consume their entire judicial calendar.[1][3][6]

The sheer volume of MDLs and the relatively low barrier to entry prompted the adoption of Rule 16.1, which encourages transferee judges to establish early vetting mechanisms. Because MDLs lack the rigorous certification gateway of class actions, corporate defendants have long argued that the system encourages the filing of unvetted or meritless claims, forcing companies to spend millions on discovery for plaintiffs who may not have even used the product in question. Rule 16.1 aims to address this inefficiency by promoting early information exchange regarding the factual bases of claims, allowing judges to utilize plaintiff fact sheets and census mechanisms to identify unsupported lawsuits before expensive merits discovery begins.[5][6]

The resolution phase highlights the starkest contrast between the two systems. In a class action, a settlement binds all class members who do not opt out, and the presiding judge must approve the settlement as fair, reasonable, and adequate under Rule 23(e). The court acts as a fiduciary for the absent class members, ensuring that the representative plaintiff and class counsel have not compromised the group's interests. In an MDL, there is no mandatory class-wide settlement and no Rule 23(e) fairness hearing for the aggregate group; instead, defendants typically negotiate a global settlement grid, and individual plaintiffs must affirmatively opt in to receive compensation based on the specific severity of their injuries.[1][2][4][6]

To facilitate these global settlements, MDL judges frequently utilize "bellwether trials." A small selection of representative cases is chosen from the massive docket and tried before a jury. The verdicts in these bellwether trials do not legally bind the other plaintiffs in the MDL, but they provide both sides with crucial data points regarding how juries perceive the evidence and the credibility of expert witnesses. These verdicts effectively set the financial parameters for the global settlement grid, allowing the parties to calculate the aggregate risk of taking the remaining thousands of cases to trial.[1][6]

If an MDL case does not settle after the bellwether process, the statute dictates that it be remanded to its original home district for trial. In practice, however, the vast majority of MDL claims are resolved through global settlements or dismissed during pretrial proceedings. This reality means that the transferee judge effectively dictates the outcome of thousands of cases without ever holding a final trial for the vast majority of plaintiffs, cementing the MDL as the most powerful, yet least understood, dispute resolution mechanism in the federal judiciary.[1][3][6]